Guardant Health (GH) CPO Monroe sells $7.6 million in stock

Guardant Health's Chief Product Officer, Monroe, sold $7.6 million worth of stock. This stock sale may raise concerns among investors regarding insider confidence. The transaction happens against the backdrop of ongoing market fluctuations, which can affect investor sentiment. As insider sales can sometimes indicate potential issues or lower confidence in a company’s performance, this sale is particularly noteworthy for shareholders of Guardant Health (GH).